Klaus Schulze-Osthoff#
| Membership Number: | 6594 |
| Membership type: | ORDINARY |
| Section: | BIOCHEMISTRY & MOLECULAR BIOLOGY |
| Affiliated section(s): | CLINICAL & VETERINARY SCIENCE |
| Elected: | 2023 |
| Main Country of Residence: | GERMANY |
| Homepage(s): | https://fit.uni-tuebingen.de/Portfolio/Details?id=2690 |
| ORCID: | 0000-0003-1443-2720 |
Present and Previous Positions
- 2008 - present Director and Chair, Department of Molecular Medicine, University of Tübingen, Germany
- 2012 - present Appointed Research Fellow of the German Cancer Research Center, Heidelberg, Germany
- 2011 - present Elected Spokesperson of the German Consortium for Translational Cancer Research (DKTK), Partner Site Tübingen
- 2009 - 2013 Appointed Scientific Director of the Comprehensive Cancer Center, Tübingen, Germany
- 2001 - 2008 Professor and founding Director of the Institute of Molecular Medicine, University of Düsseldorf, Germany
- 1999 - 2001 Professor, Department of Immunology & Cell Biology, University of Münster, Germany
- 1997 - 1998 Professor, Department of Internal Medicine I, University of Tübingen, Germany
- 1995 - 1997 Assistant Professor and Lecturer, Institute of Biochemistry and Molecular Biology, University of Freiburg, Germany
- 1992 - 1995 Junior Research Group Leader, German Cancer Research Center (DKFZ), Heidelberg, Germany
- 1990 - 1992 Postdoctoral researcher with Prof. Walter Fiers, Laboratory of Molecular Biology, University of Ghent, Belgium
Fields of Scholarship
- Inflammation and cancer
- Novel biomarkers for therapy efficacy and resistance
- Translational cancer research
- Tumor immunology
- Tumor cell senescence
- Apoptosis and cell death
Honours and Awards
- Since 2021 Appointed steering committee member, National Center for Tumor Diseases (NCT SouthWest), Germany
- Since 2019 Board member, Cluster of Excellence IFIT, Tübingen, Germany
- Since 2013 Board of Trustees, Comprehensive Cancer Center Tübingen, Germany
- Since 2011 Elected spokesperson, German Consortium for Translational Cancer Research (DKTK)
- Elected member of academic bodies at Tübingen University: Faculty Council, Research Commission; Strategy Commission
- 2016, 2005, 2002 Research Grant Award, German Cancer Aid Foundation
- 2012 - 2016 Scientific Advisory Board, Comprehensive Cancer Center, Düsseldorf, Germany
- 2011 - 2013 Spokesperson of the Collaborative Research Center 773 “Therapy resistance”, Tübingen
- Since 2010 Scientific Advisory Board, Biocheck GmbH, Münster, Germany
- 2010 Offer for the Directorship of the Leibniz Institute IfADo, Dortmund, Germany (call declined)
- 2002 - 2007 Scientific Advisory Board VIB (Vlaams Instituut voor Biotechnologie), Ghent, Belgium
- 2008 - 2012 Member of the scientific committee of the European Commission 'Emerging Newly Identified Health Risks' (SCENIHR)
- 2008 German University Medical Innovation Award
- 2007 Scientific Advisory Board, EU STREP Consortium GROWTHSTOP
- 2006 Scientific Advisory Board of Pfizer, Groton, USA
- 2000 Offer for Chair in Molecular Hepatology, University of Bonn, Germany (call declined)
- 1998 Long-Term FEBS (Federation of European Biochemical Societies) Fellowship
- 1997 Offer for the Chair position in Biochemistry, University of Halle, Germany (call declined)
- 1995 'Skin and Environment' Award, Grünenthal AG
- 1990 - 1995 Fellowship of the German Ministry of Education and Research
